Demographic and endoscopic characteristics of patients with Helicobacter pylori positive and negative peptic ulcer disease

Medical Journal of Australia

Volumn 173, Issue 10, 2000, Pages 515-519

  Xia, H H X ^a   Phung, N ^a   Kalantar, J S ^a   Talley, N J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; UREASE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; DEMOGRAPHY; DISEASE ASSOCIATION; DUODENUM ULCER; ENZYME ASSAY; FEMALE; GASTRODUODENAL ULCER; GASTROSCOPY; HELICOBACTER PYLORI; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PEPTIC ULCER; PREVALENCE; PROSPECTIVE STUDY; SEROLOGY; STOMACH ULCER;

EID: 0034693774     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2000.tb139318.x     Document Type: Article

References (29)

1. 2-receptor antagonists
2. Quality of life and relapse of duodenal ulcer before and after eradication of Helicobacter pylori
3. Helicobacter pylori and peptic ulcer
4. Helicobacter pylori in peptic ulcer disease
5. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration
6. Pyloric campylobacter infection and gastroduodenal disease
7. Pylori CLO in the human stomach
8. Low prevalence of Helicobacter pylori in an Australian duodenal ulcer population: NSAIDitis or the effect of ten years of H. pylori treatment?
9. Can Helicobacter pylori serology still be applied as a surrogate marker to identify peptic ulcer disease in dyspepsia?
10. The epidemiology of peptic ulcer mortality 1953-1989: A birth cohort analysis
11. Temporal trends and geographical variations of peptic ulcer disease
12. Prospects for improved therapy for Helicobacter pylori infection
13. Helicobacter pylori-negative duodenal ulcer
14. Helicobacter pylori-negative duodenal ulcer
15. Helicobacter pylori-negative gastric ulcer
16. Helicobacter pylori-negative duodenal and pyloric ulcer: Role of NSAIDs
17. The endoscopic assessment of esophagitis: A progress report on observer agreement
18. Metronidazole- and clarithromycin-resistant Helicobacter pylori in dyspeptic patients in Western Sydney as determined by testing multiple isolates from different gastric sites
19. Antral-type mucosa in the gastric incisura (antralization) - A link between Helicobacter pylori infection and intestinal metaplasia?
20. Classification and grading of gastritis. The updated Sydney System
21. High sensitivity and specificity of a laboratory-based serological test, pylori DTect ELISA, for detection of Helicobacter pylori infection
22. A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group
23. Is Helicobacter pylori negative duodenal ulcer a separate disease?
24. Epidemiology of peptic ulcer in Australia
25. Stress and peptic ulcer disease
26. The endoscopic diagnosis of duodenal ulcer disease. A randomized clinical trial of bias and of interobserver variation
27. Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding
28. Evidence of aspirin use in both upper and lower gastrointestinal perforation
29. Pattern of non-steroidal anti-inflammatory drug use in Australia 1990-1994. A report from the Drug Utilization Sub-Committee of the Pharmaceutical Benefits Advisory Committee